MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$25,118K
Net Income
-$122,609K
Net Profit Margin
-488.13%
EPS
-$1.14
Unit: Thousand (K) dollars
Revenue Breakdown
Product
License And Service
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
25,118
10,734
6,161
143
Cost of product revenue
154
200
269*
-
Research and development
99,850
100,081
85,053
90,464
Selling, general and administrative
57,573
50,831
54,505*
52,265
Total operating expenses
157,577
151,112
139,827
142,729
Loss from operations
-132,459
-140,378
-133,666
-142,586
Interest income
12,027
12,664
11,156
12,544
Other (expense) income, net
-423
-131
-125
-49
Total other income, net
11,604
12,533
11,031
12,495
Loss before income taxes
-
-
-122,770*
-130,091
Income tax expense
-
-
45*
-
Loss before equity method investment
-
-
-122,815*
-
Loss on equity method investment
-
-
0*
0
Net loss
-120,855
-127,845
-122,815
-130,091
Unrealized loss (gain) on investment securities
-1,899
-3,147
-206
594
Unrealized gain (loss) on foreign currency
145
28
-123
-21
Total other comprehensive income (gain)
-1,754
-3,119
-329
573
Comprehensive loss
-122,609
-130,964
-123,144
-129,518
Basic EPS
-1.14
-1.23
-1.295
-1.38
Diluted EPS
-1.14
-1.23
-1.295
-1.38
Basic Average Shares
105,560,000
104,099,000
95,120,000
94,215,000
Diluted Average Shares
105,560,000
104,099,000
95,120,000
94,215,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$122,609K
(-5.68%↓ Y/Y)
Interest income
$12,027K
(-10.61%↓ Y/Y)
Net loss
-$120,855K
(-4.51%↓ Y/Y)
Total other
comprehensive income (gain)
-$1,754K
(-360.37%↓ Y/Y)
Total other income,
net
$11,604K
(-13.88%↓ Y/Y)
Unrealized gain (loss) on
foreign currency
$145K
(526.47%↑ Y/Y)
Product
$24,038K
License And Service
$1,080K
Other (expense)
income, net
-$423K
Loss from operations
-$132,459K
(-2.59%↓ Y/Y)
Unrealized loss (gain) on
investment securities
-$1,899K
(-447.26%↓ Y/Y)
Total revenue
$25,118K
(2336.28%↑ Y/Y)
Total operating
expenses
$157,577K
(21.08%↑ Y/Y)
Research and development
$99,850K
(24.34%↑ Y/Y)
Selling, general and
administrative
$57,573K
(15.51%↑ Y/Y)
Cost of product
revenue
$154K
Buy us a coffee
Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX)